Taken together, these data demonstrate that specific inhibition of TNF-β-promoted TNF-βR pathways in CRC cells by resveratrol, at least partially, is one of the multitargeting mechanisms of anti-tumorigenic properties of resveratrol. Here, TNFRSF1B is linked to colorectal carcinoma.